News and reflections from the world of AI

    September 1, 2020

    Lundbeck case study: quantitative assessment with AI

    Quantitative assessment of alpha-synuclein pathology with AI Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s. PD affects around 10 million people worldwide. α-synuclein is a neuronal protein that is linked genetically and neuropathologically to PD.
    Written by Aiforia
    September 1, 2020

    Does deep learning AI provide a promising alternative to stereology?

    Introduction Analyzing three dimensional objects has always been a challenge for researchers who wish to find truthful, unbiased information. This is true especially in the field of neuroscience, where the investigator is often faced with detailed networks of cells in expansive areas. The number one tool enabling this analysis for the past few decades is stereology. Regarded as time efficient and ...
    Written by Aiforia
    September 1, 2020

    Orion pharma case study: accelerating preclinical neurotoxicity analysis with AI

    AI enables efficient preclinical neurotoxicity analysis at Orion pharma
    Written by Aiforia
    September 1, 2020

    Sanofi case study: Parkinson's disease research with AI

    Can Kayatekin, Senior Scientist at Sanofi, runs a group in his lab studying Parkinson’s disease (PD). Their mission is to find targets for therapeutic intervention and to elucidate the disease’s pathophysiology. One of the most time-consuming aspects of his team’s job is cell counting, specifically counting neurons positive for Tyrosine hydroxylase (Th), an enzyme known to be significant in PD.
    Written by Aiforia
    September 1, 2020

    Parkinson's disease case study: neuron quantification with AI

    “From 45 minutes to only 5 seconds” Neurodegenerative diseases are a growing burden for our ageing population. Two researchers, each running their own labs at the University of Helsinki in Finland, are addressing this through studying the biological mechanisms of these diseases with the ultimate goal of developing effective therapies. Merja Voutilainen and Mikko Airavaara are both based at the ...
    Written by Aiforia
    September 1, 2020

    Case study: Alzheimer's disease research with AI at Massachusetts General Hospital

    Case study with Ashley Scherlek, Research Technician at Massachusetts General Hospital (MGH) Ashley Scherlek, a Research Technician II at MGH working on Alzheimer’s disease, delegates her image analysis tasks to an artificial intelligence model which she created. Ashley is not a data scientist nor did she have previous experience with AI. She used Aiforia’s AI development software, Aiforia ...
    Written by Aiforia
    1 2 3